[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Interview on the NHS in the UK", "description": "A short interview for those intrested in the NHS and the philisopichal approach to health care", "link": "https://www.youtube.com/watch?v=F2HNp42rz9I", "date_published": "2021-09-02 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Risks following infection versus vaccination", "description": "UK, (England), Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study\n\nhttps://www.bmj.com/content/374/bmj.n1931\n\nhttps://www.bbc.co.uk/news/health-58347434\n\nProf Julia Hippisley-Cox\n\nPeople vaccinated with first doses, 16 or over\n\nN = 29,121,633\n\nOxford-AstraZeneca (ChAdOx1 nCoV-19)\n\nN = 19,608,008\n\nPfizer-BioNTech (BNT162b2mRNA)\n\nN = 9,513,625\n\nPeople testing positive SARSCoV-2\n\nN = 1,758,095\n\nWithin 28 days of three exposures\n\nFirst dose of the ChAdOx1 nCoV-19 vaccine\n\nFirst dose of the BNT162b2 mRNA vaccine\n\nSARS-CoV-2 positive test\n\nFor every 10 million people vaccinated with the AstraZeneca\n\nAn extra 107 would be hospitalised or die from thrombocytopenia\n\n(1 in 93,459)\n\n9 times lower than the risk following an infection\n\nAn extra 66 would be hospitalised or die from blood clots in the veins\n\nNearly 200 times lower than the risk following an infection\n\nFor every 10 million people vaccinated with the Pfizer\n\nAn extra 143 extra strokes would be seen\n\n(1 in 69,930)\n\n12 times lower than the risk following an infection\n\nMyocarditis and pericarditis\n\nChest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart\n\nhttps://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-june-25-2021\n\nhttps://www.cdc.gov/mmwr/volumes/70/wr/mm7027e2.htm\n\n52 million doses to 12\u201329 years\n\n1,226 reports of myocarditis after mRNA vaccination 42,414\n\nOne in 42,414\n\nData demonstrate increased risks, particularly within the seven days following the second dose\n \nThe observed risk is higher among males under 40 years of age compared to females and older males\n\nRisk is highest in males 12 through 17 years of age", "link": "https://www.youtube.com/watch?v=Sk4UoAkLaDU", "date_published": "2021-09-02 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Booster doses effective", "description": "BNT162b2 vaccine booster dose protection: A nationwide study from Israel \n\nhttps://www.gov.il/BlobFolder/reports/vaccine-efficacy-safety-follow-up-committee/he/files_publications_corona_booster-27082021.pdf\nBackground\n\nOn July 30, 2021\n\nThird (booster) dose of the Pfizer BNT162b2\n\nApproved in Israel for 60 years or older, who had been fully vaccinated\n\nAt least five months previously\n\nWe estimate the reduction in relative risk for confirmed infection and severe COVID-19\n\nPer person-days at risk\n\nJuly 30 and August 22, 2021\n\nDynamic cohorts\n\nMoved from \u2018non-booster\u2019 to join the \u2018booster\u2019 cohort 12 days later\n\nNo-booster cohort\n\n4.0 million person- days\n\n3,473 confirmed infections\n\n330 cases of severe COVID-19\n\nBooster cohort\n\n3.4 million person-days\n\n313 confirmed infections\n\n32 cases of severe COVID-19\n\nTwelve days or more after the booster dose we found\n\n9.6 - 11.4 - 13.4 fold decrease in the relative risk of confirmed infection\n\n9.5 - 15.5 fold decrease in the relative risk of severe illness\n\nDiscussion \n\nIf waning immunity to Delta is 50% protection against infection at more than 6 months\n\nA booster - vaccinated individual susceptible to infection would decrease to 5% relative to unvaccinated\n\nTherefore vaccine efficacy for booster-vaccinated individuals to 95%\n\n(similar to the original \u201cfresh\u201d vaccine efficacy against the Alpha strain)\n\nOur findings give clear indications of the effectiveness of a booster dose even against the currently dominant Delta variant \n\nUS and UK current thinking\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html\nhttps://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation\nModerately to severely immunocompromised people", "link": "https://www.youtube.com/watch?v=MDx8nRWuC3Q", "date_published": "2021-09-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]